U.S. Markets open in 8 hrs 27 mins

Galena Biopharma, Inc. (GALE)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5926+0.03 (+4.81%)
At close: 4:00PM EDT
People also watch
IMUCCYTRINOCLDXTHLD
Interactive chart
Previous Close0.5654
Open0.5610
Bid0.4150 x 100
Ask0.8200 x 2500
Day's Range0.5578 - 0.5950
52 Week Range0.1600 - 4.7500
Volume746,797
Avg. Volume1,193,250
Market Cap22.18M
Beta2.18
PE Ratio (TTM)-0.45
EPS (TTM)-1.31
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • AbbVie and J&J Present Positive Imbruvica Leukemia Data
    Zacks10 days ago

    AbbVie and J&J Present Positive Imbruvica Leukemia Data

    AbbVie Inc. (ABBV) recently announced positive data from a pooled analysis of three phase III studies evaluating its cancer drug, Imbruvica (ibrutinib).

  • Associated Press14 days ago

    Galena Biopharma reports 1Q loss

    On a per-share basis, the San Ramon, California-based company said it had a loss of 45 cents. Losses, adjusted to account for discontinued operations, came to 9 cents per share. In the final minutes of ...

  • GlobeNewswire14 days ago

    Galena Biopharma Reports First Quarter 2017 Financial Results

    SAN RAMON, Calif., May 10, 2017-- Galena Biopharma, Inc., a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial results ...